INSA lays out protective capacity of vaccines

Reporting to this mornings meeting between the government and experts at Infarmed, INSA public health institute specialist in epidemiology Ausenda Machado has revealed that the first dose of mRNA vaccines (Pfizer and Moderna) confer 37% protection against SARS-CoV-2 infection in the 65-79 year age grouping, and 35% in the over 80s. Second dose increases protection to 78% and 68% respectively. When it comes to hospitalisation, Mr Machado says the mRNA vaccines are 85% effective in people over the age of 80 (as long as they have had both doses, and a 14-day period since the 2nd dose).